• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home ENT

Secondary mastoid obliteration improves quality of life for patients with chronic otitis media

byAndrew Bishara
September 27, 2013
in ENT, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. When compared to primary mastoid obliteration, secondary obliteration resulted in a more pronounced, though not statistically significant, improvement in quality of life.

2. In both the secondary and primary obliteration groups, a significant improvement in quality of life was noted.

Evidence Rating Level: 2 (Good)

Study Rundown: During mastoidectomy, cavity obliteration and reconstruction of the bony external ear canal is often recommended. If the obliteration is not completed during the procedure (primary obliteration), the cavity may not heal and a secondary obliteration procedure may be necessary. The authors used the Glasgow Benefit Inventory to assess quality of life (QOL) changes in patients following primary and secondary mastoid cavity obliteration. A subsequent analysis demonstrated a more pronounced, though not statistically significant, QOL improvement in the secondary obliteration group. The much smaller number of patients in the secondary obliteration group may explain the lack of significance.

Click to read the study in Journal of Otolaryngology – Head & Neck Surgery

RELATED REPORTS

Microneedling with tranexamic acid may improve outcomes for patients with melasma

Long term safety and efficacy of rabies monoclonal antibody in post-exposure prophylaxis

Tirzepatide leads to greater weight loss than semaglutide among adults with obesity

Relevant Reading: Quality-of-life assessment after primary and revision ear surgery using the chronic ear survey

In-Depth [retrospective cohort]: This study compared the QOL improvement in 46 patients who had primary mastoid cavity obliteration and 12 who needed secondary obliteration. The 58 patients completed the Glasgow Benefit Inventory, either in person or over the phone. In the secondary obliteration group 83% of the subjects reported improvement in QOL compared to only 72% in the primary obliteration group. The secondary group also reported greater improvement of QOL across the GBI subscales (general, physical, and social). While these differences were noted clinically, they were not statistically significant on a Mann Whitney U test (p = .10, p = .15, and p = .43 respectively).

By Amir Tarsha and Chaz Carrier

More from this author: Local excision inferior to major resection in T1-2 colon cancer and T2 rectal cancer

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Previous Post

Alefacept may be effective therapy in newly diagnosed type 1 diabetics

Next Post

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

RelatedReports

Dermatology

Microneedling with tranexamic acid may improve outcomes for patients with melasma

August 26, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Emergency

Long term safety and efficacy of rabies monoclonal antibody in post-exposure prophylaxis

August 26, 2025
Parental conceptions of weight are becoming increasingly inaccurate
Cardiology

Tirzepatide leads to greater weight loss than semaglutide among adults with obesity

August 26, 2025
USPSTF recommends chemoprevention for women at high risk for breast cancer
Endocrinology

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

August 26, 2025
Next Post
Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation

The CRASH-2 trial: Tranexamic acid in trauma patients [Classics Series]

Pediatric post-operative intussusception more common in open surgery

Enriching fat grafts with stem cells improves outcomes

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Microneedling with tranexamic acid may improve outcomes for patients with melasma
  • Long term safety and efficacy of rabies monoclonal antibody in post-exposure prophylaxis
  • Tirzepatide leads to greater weight loss than semaglutide among adults with obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.